| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Charles B O'Keeffe last filed a Form 4 in February 2025, as Director at CPRX. Charles B O'Keeffe's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Charles B O'Keeffe has 13 Form 4 filings on record from November 2022 to February 2025, all as Director at Catalyst Pharmaceuticals (CPRX), 2022–2025.
The 17 reported transactions were 10 option exercises, 6 option or other derivative awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $1.4M.
The only open-market sale was 87,985 shares of CPRX at an average $16.04 on November 15, 2022, about $1.4M. Twelve months later CPRX was down 14%.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Director | Sell | 87,985 | $16.04 | $1,411,015.44 | -13.5% | -2.2% | -14.1% |